With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (L LMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Alternative to insulin and GLP1
From the β-cell to the center: the versatile role of amylin
- Hormone balance and longevity
Ageing is not a substitution diagnosis
- Cardiovascular risk
Bad news for young men with T2D
- Case Report
6-year-old child with central retinal artery occlusion
- Low grade serous ovarian carcinoma (LGSOC)
Opening up new horizons through combination therapies
- Rare diseases
Yellow nail and Swyer-James syndrome
- Results of a systematic review and meta-analysis
Physical activity as a therapeutic approach for depression and anxiety disorders
- Underestimated risk - findings from a US cohort